<DOC>
	<DOC>NCT00366483</DOC>
	<brief_summary>To assess the safety, tolerability and pharmacokinetics of single and multiple ascending oral doses of lecozotan SR in healthy young and elderly subjects.</brief_summary>
	<brief_title>Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Young subjects: Men aged 18 to 45 years. Elderly subjects: Men and women ≥ 65 years of age. Body mass index in the range of 18 to 30 kg/m2 and body weight ≥ 50 kg. Healthy as determined by the investigator. History of any neuropsychiatric disorder. History of drug or alcohol abuse.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>healthy young volunteers</keyword>
	<keyword>healthy elderly volunteers</keyword>
	<keyword>Alzheimer's disease</keyword>
	<keyword>5HT1A antagonist</keyword>
	<keyword>Health</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>